Ratings Summary for LUPRON

Overall Patient opinion of LUPRON: 2.7 (somewhat satisfied)

(based on 854 reviews ) (updated May 6, 2025)

Ratings by Age Group for LUPRON
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	16	2.5
Age 18 to 24	108	2.8
Age 25 to 34	303	2.8
Age 35 to 44	224	2.8
Age 45 to 54	112	2.5
Age 55 to 64	33	2.8
Age 65 to 74	34	2
Age 75 and up	9	2.2

Ratings by Sex for LUPRON
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	95	2.35789473684211
Female	747	2.85408299866131
Not Specified	11	1.90909090909091

Would you like to find reviews for LUPRON taken for a specific reason or resulting in a specific side effect?

Filter Results for LUPRON

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for LUPRON

Check here for Ask a Patient's Adverse Event Summary for LUPRON based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

LUPRON (LEUPROLIDE ACETATE): Teatment of advanced prostatic cancer. Management of endometriosis, including pain relief and reduction of endometriotic lesions; preoperative hematologic improvement of women with anemia caused by fibroids FDA Approval Date: 1985-04-09 (Sources: U.S. Centers for Medicare Services, FDA)